Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $59.904 million which beat the analyst consensus estimate of $58.870 million by 1.76 percent. This is a 21.25 percent increase over sales of $49.405 million the same period last year.